'New Medical Devices Rules Would Usher In Rejuvenated Regulated Atmosphere'
Express Healthcare|July, 2017

Suresh Kumar, Senior VP, Product Services TÜV SÜD South Asia, in an interaction with Viveka Roychowdhury, opines that the medical devices industry will receive an exponential boost once regulations are in place

Viveka Roychowdhury
'New Medical Devices Rules Would Usher In Rejuvenated Regulated Atmosphere'

TÜV SÜD was the first independent certification firm in India to receive an accreditation from National Accreditation Board for Certifying Bodies (NABCB) to grant certifications for ISO 13485 & ICMED Schemes. What is the certification process? Does it involve site audits, etc.? What are the parameters required for such certifications? How many such certifications have been granted so far? And what are the costs involved for manufacturers to obtain, maintain and renew such certifications?

Medical device manufacturers can apply to TÜV SÜD for ISO 13485 and ICMED schemes to obtain certifications that indicate their products comply with regulations for domestic use and exports. The initial certification process entails onsite documentation and compliance audits. Once the organisation meets the quality requirements, it is awarded a certification for three years. The validity of the certification is subject to the successful completion of announced surveillance audits in the following two years. In ICMED schemes, surveillance audits are conducted spontaneously. Since this is a comparatively new accreditation, we have a considerable number of certifications that are in the pipeline for final closure. The costs for obtaining these certifications are commensurate with global standards and consists of elements such as annual certificate license and certification body review services.

TÜV SÜD is also part of the Medical Device Single Audit Programme (MDSAP), which is aimed to help manufacturers get their devices into multiple global markets through a single audit. MDSAP was slated for official implementation from January 2017. What is the update on this? What is the response?

هذه القصة مأخوذة من طبعة July, 2017 من Express Healthcare.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة July, 2017 من Express Healthcare.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من EXPRESS HEALTHCARE مشاهدة الكل
Healthcare Communication In India
Express Healthcare

Healthcare Communication In India

Dr Alexander Thomas, President, Association of Healthcare Providers - India (AHPI) and Divya Alexander, Research Consultant, in a first of a series provide detailed insights on healthcare communication that explores its different aspects in an Indian context

time-read
6 mins  |
March 2020
The growth story
Express Healthcare

The growth story

Himanshu Baid, Managing Director, Poly Medicure elucidates on how Poly Medicure has served the medical fraternity for over 22 years and owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team

time-read
2 mins  |
March 2020
Main objective of Indian Joint Registry is to help patient safety, bring stability to the market
Express Healthcare

Main objective of Indian Joint Registry is to help patient safety, bring stability to the market

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint registry to track such patients and avoid future episodes. Richard Armstrong, Head, Health Registries, Northgate Public Services tells Viveka Roychowdhury about the response to the Indian Joint Registry

time-read
4 mins  |
March 2020
Express Healthcare

UNDERSTANDING THE RELEVANCE OF HEALTHCARE RESEARCH

India as a nation has followed the west for decades when it comes to research-based treatments. The sun is fast setting on this methodology and there is a massive need to invest in healthcare research in the country

time-read
8 mins  |
March 2020
I have witnessed the steady technical advances in ultrasound
Express Healthcare

I have witnessed the steady technical advances in ultrasound

Dr BS Rama Murthy, Consultant Radiologist, Srinivasa Ultrasound Scanning Centre and Chief Patron, Medical Ultrasound Society of Karnataka, Coordinator – Fetal Foundation of India, talks about the evolution of ultrasound and how foetal imaging has improved over the years, in an interaction with Express Healthcare

time-read
4 mins  |
March 2020
Radiology has a bright future and has been at the forefront of healthcare
Express Healthcare

Radiology has a bright future and has been at the forefront of healthcare

Radiology has a major role to play when it comes to healthcare. Dr Piyush Saxena, Consultant Radiologist and Chief of MR imaging, Vishesh Hospital and Diagnostics, Indore, MP in an exclusive conversation with Express Healthcare disscuses the impact of radiology on healthcare and how newer innovations from GE Healthcare has helped improve healthcare delivery as well as patient comfort

time-read
4 mins  |
March 2020
The Pill For India's Ailing Medical Eductaion System
Express Healthcare

The Pill For India's Ailing Medical Eductaion System

Medical education in India is mired with a host of controversies and is trudging along a rough path.

time-read
6 mins  |
February 2020
RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai
Express Healthcare

RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai

Invites renowned Japanese cardiac interventionist, Dr Kinzo Ueda to India to share his experiences and insights with cardiologists at Apollo Hospitals and Sri Ramachandra Institute of Higher Education and Research

time-read
8 mins  |
February 2020
Roche Diagnostics partners with SRL Dr Avinash Phadke Lab
Express Healthcare

Roche Diagnostics partners with SRL Dr Avinash Phadke Lab

Roche’s first partner for cobas pro solution is SRL Dr Avinash Phadke Lab in Mumbai. The solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients

time-read
5 mins  |
February 2020
Pharmacogenomics- Essential to end the era of trial and error medicine
Express Healthcare

Pharmacogenomics- Essential to end the era of trial and error medicine

Chandni Luthra, Co-Founder, FutureMed elucidates on the impact that trial and error has had on patients earlier, but in today's age adverse drug reactions is considered to be the fourth leading cause of death worldwide and has almost doubled in India in the last three years

time-read
3 mins  |
February 2020